Back to Search Start Over

Human prolactin regulates transfected MMTV LTR-directed gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones

Authors :
Noorbibi K. Day
Robert W. Engelman
Robert A. Good
Soichi Haraguchi
Source :
International Journal of Cancer. 52:928-933
Publication Year :
1992
Publisher :
Wiley, 1992.

Abstract

Prolactin plays a key role in the regulation and growth of mammary cells, and influences tumor promotion. We have shown that chronic energy restriction intake depresses prolactin levels, inhibits production of MMTV proviral DNA and proto-oncogene expression in mammary glands and prevents development of mammary tumors. Since the expression and proto-oncogene activation of MMTV are regulated by promoter/enhancer elements within its long terminal repeat (LTR), in the present study we used a chloramphenicol acetyl transferase (CAT) reporter gene system and gene transfection methods to study the effect of prolactin on MMTV LTR using a human ductal carcinoma cell line T47D stably or transiently transfected with a plasmid consisting of the LTR upstream of CAT gene. Human prolactin or dexamethasone induced, respectively, a 2-fold or 6-fold increase in CAT activity compared with background CAT activity in the absence of hormones. However, the combination of human prolactin and dexamethasone strongly enhanced (20-fold) induction of the LTR compared with the control. Human prolactin also showed a synergistic effect with progesterone on LTR induction. Both LTR and CAT genes needed to be linked for induction of CAT activity by prolactin and dexamethasone. Our results indicate that human prolactin can act synergistically with steroid hormones to regulate MMTV LTR-directed gene expression in transfected T47D cells. © 1992 Wiley-Liss, Inc.

Details

ISSN :
10970215 and 00207136
Volume :
52
Database :
OpenAIRE
Journal :
International Journal of Cancer
Accession number :
edsair.doi.dedup.....1e876df1cd01d7e0e0d8cf9db4d86bfb
Full Text :
https://doi.org/10.1002/ijc.2910520617